Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155597 | SCV000205305 | likely benign | not specified | 2013-03-26 | criteria provided, single submitter | clinical testing | Thr495Thr in exon 13 of ACTN2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 1/196 Tuscan chromo somes by the 1000 Genomes Project (dbSNP rs201179281). Thr495Thr in exon 13 of ACTN2 (rs201179281; allele frequency = 1/196) |
Ce |
RCV000994294 | SCV001147739 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ACTN2: BP4, BP7 |
Labcorp Genetics |
RCV001444782 | SCV001647793 | likely benign | Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390354 | SCV002701619 | likely benign | Cardiovascular phenotype | 2019-09-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000155597 | SCV001919451 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000994294 | SCV001951488 | likely benign | not provided | no assertion criteria provided | clinical testing |